For the future of metabolic therapeutics, survodutide's Phase 2 data are encouraging, particularly for MASH where the glucagon mechanism provides a uniquely differentiated approach
Int J Endocrinol 2017(1):1297658
Recently, the first approval for a dual-receptor agonist marks an important step in this development
Management of side effects: Though side effects of semaglutide are typically mild, including nausea and diarrhea, B12 is being studied as a potential strategy to lessen these effects when compounded with semaglutide
The post says portable coolers with ice packs hold temperature for several hours on short trips, and it suggests insulated bags with temperature-regulating packs plus hotel refrigerators for longer travel
PubMed Sweeney KM, Wright GA, Glenn Brice A, Doberstein ST